Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/RHU.0b013e31819db6db http://scihub22266oqcxt.onion/10.1097/RHU.0b013e31819db6db 19300288!ä!19300288 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Rheumatol 2009 ; 15 (3): 127-9 Nephropedia Template TP {{tp|p=19300288|t=2009. Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken for Raynaud phenomenon |pdf=|usr=}}{{19300288}} gab.com Text Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken for Raynaud phenomenon JO: J Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=19300288 #FOAvip Rheumatologists are often asked to evaluate patients with Raynaud phenomenon. Occasionally, an alternate explanation is revealed such as acrocyanosis. Methemoglobinemia and sulfhemoglobinemia are rare causes of cyanosis that can be medication-induced. Both are known complications of therapy with phenazopyridine. We report an unusual case of a 45-year-old woman in whom sulfhemoglobinemia from chronic therapy with phenazopyridine was misdiagnosed as due to Raynaud phenomenon and limited scleroderma. This case illustrates the importance of taking into account medication-related adverse events when evaluating patients with Raynaud-like phenomenon. Twit Text FOAVip Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken for Raynaud phenomenon ????J Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=19300288 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=19300288 #FOAvip English Wikipedia <ref>{{Cite pmid|19300288}}</ref> Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken for Raynaud phenomenon #MMPMID19300288 Kermani TA; Pislaru SV; Osborn TG J Clin Rheumatol 2009[Apr]; 15 (3): 127-9 PMID19300288show ga Rheumatologists are often asked to evaluate patients with Raynaud phenomenon. Occasionally, an alternate explanation is revealed such as acrocyanosis. Methemoglobinemia and sulfhemoglobinemia are rare causes of cyanosis that can be medication-induced. Both are known complications of therapy with phenazopyridine. We report an unusual case of a 45-year-old woman in whom sulfhemoglobinemia from chronic therapy with phenazopyridine was misdiagnosed as due to Raynaud phenomenon and limited scleroderma. This case illustrates the importance of taking into account medication-related adverse events when evaluating patients with Raynaud-like phenomenon. |*Sulfhemoglobinemia/chemically induced/complications/diagnosis[MESH] |Adult[MESH] |Anesthetics, Local/*adverse effects[MESH] |Cyanosis/*etiology[MESH] |Diagnosis, Differential[MESH] |Dyspnea/etiology[MESH] |Female[MESH] |Humans[MESH] |Phenazopyridine/*adverse effects[MESH] |Polypharmacy[MESH]Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken (epmc).pdf DeepDyve Pubget Overpricing